CCM
IART icon

Cazenove Capital Management’s Integra LifeSciences IART Stock Holding History

Cazenove Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$44.2K Buy
+2,955
New +$43.3K 0.04% 133

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cazenove Capital Management's IART Position: Q2 2013 in Review

Cazenove Capital Management opened a new position in Integra LifeSciences (IART) in Q2 2013: 2,955 shares worth $44.2K. The stake represents 0.04% of the portfolio and ranks #133 among its holdings.

129 funds tracked by Wall St. Rank hold IART as of Q2 2013.

  • Cazenove Capital Management held 2,955 shares of Integra LifeSciences worth $44.2K as of Q2 2013.
  • Integra LifeSciences was a new Cazenove Capital Management position in Q2 2013.
  • Integra LifeSciences made up 0.04% of Cazenove Capital Management's portfolio in Q2 2013, its #133 holding.
  • 129 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2013.

Based on Cazenove Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.